In vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infection
- 31 August 1994
- journal article
- Published by Elsevier in Toxicology in Vitro
- Vol. 8 (4) , 677-683
- https://doi.org/10.1016/0887-2333(94)90042-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- 2',3'‐Dideoxycytidine (ddC) toxic neuropathyNeurology, 1993
- Antiretroviral therapy: reverse transcriptase inhibitionAntimicrobial Agents and Chemotherapy, 1992
- In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivityChemico-Biological Interactions, 1991
- Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudineThe American Journal of Medicine, 1991
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- Biogenesis of MitochondriaAnnual Review of Cell Biology, 1988
- 3′‐Azido‐3′‐deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cellsBritish Journal of Haematology, 1988
- Severe Polymyositis-like Syndrome Associated with Zidovudine Therapy of AIDS and ARCNew England Journal of Medicine, 1988
- A model for fast axonal transportCell Motility, 1985